Dihydrolipoamide acetyltransferase (DLAT) and lipoic acid synthetase (LIAS), two key cuproptosis regulators, are abnormally expressed in non-small cell lung cancer (NSCLC) and are potential biomarkers for clinical diagnosis. The gene discussed is DLAT; the disease is non-small cell lung carcinoma.